CellaVision AB (publ) (OTCMKTS:CLVSF) Stock Price Down 14.9% – Time to Sell?

CellaVision AB (publ) (OTCMKTS:CLVSF)’s stock price traded down 14.9% during mid-day trading on Friday . The company traded as low as $13.49 and last traded at $13.49. 400 shares changed hands during trading, a decline of 33% from the average session volume of 600 shares. The stock had previously closed at $15.85.

CellaVision AB (publ) Trading Down 14.9%

The stock has a fifty day moving average of $15.98 and a 200-day moving average of $16.94.

About CellaVision AB (publ)

CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.

The company’s core offering revolves around its digital microscopy instruments and proprietary software.